Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy ...(is also developing its ToleroTrans organ...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
Circassia Achieves Successful Phase II Clinical Results With Toleromune(R) Anti-Allergy Technology
Date:9/10/2008
is also developing its ToleroTrans organ anti-rejection technology, which uses a similar approach to down-regulate immune responses in transplant patients.
For more information please visit http://www.circassia.co.uk.
'/>"/>
| SOURCE Circassia Ltd Copyright©2008 PR Newswire. All rights reserved |
Related medicine technology :
1. Agile Therapeutics Achieves Phase 2 Study Endpoints in Key Clinical Trials with New, Innovative Low-Dose Contraceptive Patch
2. Intermezzo(R) 3.5 mg Achieves Greater Early Bioavailability Than Ambien(R) 10 mg Despite 65% Lower Dose
3. TriMix Gel Achieves Success Among Men Who Have Failed to Achieve Erections With Viagra, Levitra and Cialis Type Tablets
4. Prescient Medical, Inc. Achieves Successful Clinical Debut of vProtect(TM) Luminal Shield
5. Pharmacopeias First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients
6. CureDMs Diabetes Therapy Achieves Major Development Milestone
7. EntreMed Achieves a Key Milestone Through Initiation of ENMD-2076 Clinical Program
8. Bionomics Achieves US$1 Million Milestone Payment from Genmab
9. Lotus Pharmaceuticals, Inc. Achieves Significant Milestones in the Development of Isosorbide Mononitrate Sustained Release Tablets
10. Tolerx Achieves Milestone with Completion of Phase Ib Clinical Study of TRX1 in Cutaneous Lupus Erythematosus
11. Surface Logix Achieves Objectives With SLx-2101 in Phase 2a Clinical Trial in Hypertension
Post Your Comments:
(Date:12/4/2009)... WASHINGTON, Dec. 4 Chemistry World recently highlighted ... Research and Manufacturers of America ( PhRMA ) that ... and related conditions. ,, The report found that ... antivirals. These drugs are either in human clinical trials or ...
(Date:12/4/2009)... Inc., a wholly-owned subsidiary of Volcano Corporation (Nasdaq: ... testing of a novel integrated light source architecture for ... design raises the bar on imaging speed and overcomes ... light sources. This approach to optical engines builds ...
(Date:12/4/2009)... ("NWBT" or the "Company") (OTC Bulletin Board: NWBO) announced ... allowed its patent application on a system for automation ... Company,s DCVax® therapeutic cancer vaccines. These initial manufacturing ... dendritic cells (which are the critical ingredient) in the ...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 2Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 3Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 4Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing 5AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 1AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 2AEterna Zentaris to Complete Phase 3 Clinical Trial of Macimorelin 28AEZS 130 29 as First Oral Diagnostic Test for Growth Hormone Deficiency 14520 3NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 1NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 2NovaBay Pharmaceuticals Expands Management Team 3B Names Mark Anderson Ph D as Chief Scientific Officer 5549 3ERISAclaim com Announced Free ERISA Webinar for Healthcare Overpayment Dispute and Claim Denials in Response to Increasing High Demand from the 246 T 59724 1ERISAclaim com Announced Free ERISA Webinar for Healthcare Overpayment Dispute and Claim Denials in Response to Increasing High Demand from the 246 T 59724 2ERISAclaim com Announced Free ERISA Webinar for Healthcare Overpayment Dispute and Claim Denials in Response to Increasing High Demand from the 246 T 59724 3ERISAclaim com Announced Free ERISA Webinar for Healthcare Overpayment Dispute and Claim Denials in Response to Increasing High Demand from the 246 T 59724 4[0] U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS[0] Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging[0] Northwest Biotherapeutics Receives Approval of US Patent for Cost Saving Automation of High-Concentration DCVax(R) Manufacturing
... Service Members, Other AmericansWASHINGTON, May 27 The Department ... of an advanced artificial arm that easily allows those ... or hold a pencil."This arm is a high-tech example ... design, and clinical use of artificial limbs to meet ...
... Kinex Pharmaceuticals will present results from a Phase 1 ... in Orlando, on May 29, 2009. The study was ... and Fox Chase Cancer Center. Dr. Alex Adjei, the ... of a phase I trial of KX2-391, a novel non-ATP ...
Other Medicine Technology:VA Studies Advanced Prosthetic Arm 2(Date:12/6/2009)... community, in cooperation with the Greater VA Healthcare System in West ... attendance is expected to soar to more than 5,000 veterans, active ... ... (PRWEB) December 6, 2009 -- Volunteer organizations and members of the ... Los Angeles, will once again create a holiday party. This year,s ...
(Date:12/5/2009)... 5 The first Football,for Hope Centre in ... its doors,today (5 December 2009). FIFA President Joseph ... Zille, 2010 FIFA World Cup Organising Committee,South Africa ... Kirsten Nematandani and Executive Mayor of the City ...
(Date:12/5/2009)... advanced Technology Center helps companies develop and test their cleaning processes. ... a variety of industries and solve problems for customers relating to ... ... December 5, 2009 -- Midbrook, Inc , a Jackson, MI-based ...
(Date:12/4/2009)... Care Investment Trust Inc. (NYSE: CRE ... Directors has declared a dividend of $0.17 per share of common ... common shareholders of record on December 14, 2009. ... Inc. is a real estate investment and finance company investing in ...
(Date:12/4/2009)... America, Inc. ("HTA"), a self-managed, non-traded, real estate investment ... agreement to acquire a three building medical office portfolio ... Wayne, Indiana for approximately $20,500,000. The closing of ... number of conditions. ,, The approximately 92,500 square foot ...
Breaking Medicine News(10 mins):Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 2Health News:17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” 3Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 2Health News:Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha 3Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 2Health News:Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification 3Health News:Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share 2Health News:Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana 2[0] 17th Annual Event Honoring 5,000 + Veterans, Military Personnel to Include Real Life “Heroes” [0] Opening of First Football for Hope Centre Heralds a New Dawn for Khayelitsha[0] Midbrook Lab Testing Provides Results for Cleaning Process Develop and Verification[0] Care Investment Trust Inc. Declares Quarterly Dividend of $0.17 Per Share[0] Healthcare Trust of America, Inc. Executes Agreement to Acquire a 92,500 Square Foot Medical Office Portfolio Located in Texas and Indiana
... The Minnesota Nurses,Association (MNA) announced today their endorsement ... Representatives, Congressional District 2., "As a veteran of ... and,informed advocate we need in Congress for meeting the ... Chair, Tom Kelly, RN.,"With his unequivocal support of the ...
... regulation of serotonin triggered sudden death in mice, researchers report, ... in the regulation of the brain chemical serotonin may be ... research suggests. , Reporting in the July 4 issue of ... serotonin levels in a mouse model resulted in sudden death ...
... condition that unexpectedly and unexplainably takes the lives of seemingly ... researchers of the European Molecular Biology Laboratory in Monterotondo, Italy, ... cot death, which remains the leading cause of death during ... published in this week,s issue of Science , reveals ...
... Dr. Thomas Hassell, former,global vice president of ... has joined IAVI as vice president for vaccine ... IAVI,s product development efforts,that are aimed at rapidly ... vaccine discovery programs., Dr. Hassell is trained ...
... from wildfires poses lethal health hazards to people ... respiratory problems such,as asthma, emphysema, and bronchitis and ... precautions during this time and call their,physician immediately ... diseases are at risk during this time," said,Norman ...
... THE IMPACT OF ... TECHNOLOGY IN HEALTHCARE ... PLANO, TX, July 3 Edition 20, Host: Dr. Kevin ... William Stead, Associate Vice Chancellor for,Strategy/Transformation & Chief Information Officer Vanderbilt ...
Other Medicine News:Health News:Minnesota Nurses Association Endorses Steve Sarvi for Congress 2Health News:SIDS Linked to Brain Chemical Dysfunction 2Health News:SIDS Linked to Brain Chemical Dysfunction 3Health News:New research sheds light on the molecular basis of crib death 2Health News:Leading Vaccine Expert Joins IAVI 2Health News:Leading Vaccine Expert Joins IAVI 3Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 2Health News:American Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air Pollution 3Health News:HEALTHCARE TECH AND THE WORLD: A MACRO PERSPECTIVE ON HOW TECHNOLOGY WILL IMPACT HEALTHCARE IN THE FUTURE 2Health News:HEALTHCARE TECH AND THE WORLD: A MACRO PERSPECTIVE ON HOW TECHNOLOGY WILL IMPACT HEALTHCARE IN THE FUTURE 3Minnesota Nurses Association Endorses Steve Sarvi for CongressSIDS Linked to Brain Chemical DysfunctionNew research sheds light on the molecular basis of crib deathLeading Vaccine Expert Joins IAVIAmerican Lung Association Urges People Living Near Wildfires to Protect Themselves Against Staggering Levels of Unhealthy Air PollutionHEALTHCARE TECH AND THE WORLD: A MACRO PERSPECTIVE ON HOW TECHNOLOGY WILL IMPACT HEALTHCARE IN THE FUTURE
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products:| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |